Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
Crohn’s disease (CD) is a chronic inflammatory disease that can be associated with intestinal and extraintestinal manifestations. Some patients are treated with infliximab, an antitumor necrosis factor-alpha (TNF-α) agent, to help them achieve and maintain clinical and biochemical remission. However...
Saved in:
Main Authors: | Ashley Fonseca, Julee Sunny, Lina M. Felipez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2021/9989729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Very Early-Onset Inflammatory Bowel Disease (VEO-IBD) Presenting with Recurrent Leukocytoclastic Vasculitis Preceded by Streptococcal Pharyngitis
by: Ashley Fonseca, et al.
Published: (2021-01-01) -
The pro-inflammatory cytokine Tumor Necrosis Factor alpha (TNF-α) in Diabetic Nephropathy
by: Alia KH Mahmoud, et al.
Published: (2024-07-01) -
Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
by: Stephan R Targan
Published: (2000-01-01) -
Pleural Fluid Cholesterol in Differentiating Exudative and Transudative Pleural Effusion
by: A. B. Hamal, et al.
Published: (2013-01-01) -
Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
by: Muhammad Mirza, et al.
Published: (2018-01-01)